-
Mashup Score: 2Reviewing New Treatment Approaches for Epidermolysis Bullosa - 2 year(s) ago
Jemima Mellerio, MD, covered recent developments for managing epidermolysis bullosa and the challenges of studying rare diseases.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Hot Topics in Skincare From AAD 2023 - 2 year(s) ago
Experts in dermatology discuss hot topics in skin care from AAD 2023 relating to skin renewal, photoprotection in patients with skin of color, next generation cleansing technologies, and the use of over the counter and prescription acne products.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Tune in to our Expert Perspective interviews on next-generation cleansing technology and other hot topics in skin care with top dermatologists Ted Lain, MD, MBA; Joshua Zeichner, MD; Amy McMichael, MD; and Patricia Farris, MD. Explore interviews here: https://t.co/JCUJPBOe9i https://t.co/FIiB83p2Me
-
-
Mashup Score: 0
Jane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Jane Bellet, MD, found her passion in running the Duke Nail Clinic for children and adults with nail abnormalities. Each day, she provides both medical and surgical management of nail disorders and plans to share pearls at the @SocietyPedsDerm Meeting. https://t.co/daz55LU1ox
-
-
Mashup Score: 2Alphyn Biologics Shares Positive Interim Results of Phase 2a Trial for AD With Secondary Bacterial Infection - 2 year(s) ago
AB-101a is a new topical treatment being investigated for mild, moderate, and severe atopic dermatitis and its immune system component.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Alphyn Biologics announced interim results from the second cohort of phase 2a clinical trial program of AB-101a, a candidate for #AtopicDermatitis. The drug is meeting all endpoints for safety and efficacy related to the immune and bacterial components. https://t.co/8ceW03VXqM
-
-
Mashup Score: 0Study Researchers Recommend Updated Clinical Guidelines to Treat Kaposiform Hemangioendotheliomas - 2 year(s) ago
A multicenter study to further explore treatment of kaposiform hemangioendotheliomas has been proposed after untreated patients did not develop Kasabach Merritt Phenomenon.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
A multicenter study to further explore treatment of kaposiform hemangioendotheliomas has been proposed after untreated patients did not develop Kasabach Merritt Phenomenon. Read more from the 2023 @SocietyPedsDerm poster session. https://t.co/7aXoYWd1c2
-
-
Mashup Score: 0
Bree will discuss the organization she founded and how it helps children with skin diseases and birthmarks.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
There are several opportunities being presented this weekend for clinicians to empower pediatric patients at the 2023 @SocietyPedsDerm Meeting in Asheville, North Carolina. One of them is @masterpiecemade led by Alanna Bree, MD. https://t.co/EW6A4tqUrw
-
-
Mashup Score: 0Ensure Patient Adherence in Pediatric Atopic Dermatitis Cases - 2 year(s) ago
Steve Feldman, MD, PhD, is part of an atopic dermatitis panel and focuses on strategies to hold pediatric patients and their parents accountable to treatment methods.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Steven Feldman, MD, PhD, shared his takeaways from memorable #atopicdermatitis cases, communication tips for adherence, and his book about patient adherence strategies. He is part of an atopic dermatitis panel at the @SocietyPedsDerm Meeting. https://t.co/rk2Aad6F1X
-
-
Mashup Score: 0
Real-world data demonstrated marked impacts on the economy on a national and personal level.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Aside from psychosocial and emotional tolls, #alopecia areata and hair loss may also have a direct and indirect impact on a nation’s overall economic burden, including detrimentally affecting cost and time. https://t.co/cyiG5dGxDx
-
-
Mashup Score: 0
Nurse practitioners and physician assistants play a crucial role in dermatology, and Dermatology Times is proud to curate content embracing and empowering the NP/PA community.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Dermatology Times is proud to curate content embracing and empowering the #NP and #PA community. As the need for dermatologic care continues to grow, we want to ensure their experiences are heard, insight is shared, and hunger for knowledge is fulfilled. https://t.co/L9Krm2SbuH
-
-
Mashup Score: 0
IL-17A was antagonized by secukinumab, while several other serum levels were decreased in expression.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
In patients with #psoriasis, secukinumab plays a vital role in antagonizing and decreasing the expression of several serum cytokines. https://t.co/q8NCVfVYXr
-
Jemima Mellerio, MD, covered recent developments for managing epidermolysis bullosa and the challenges of studying rare diseases during the 2023 @SocietyPedsDerm Meeting in Asheville, North Carolina. https://t.co/Iq6xf24bIi